MLchartDataset catalogue

autologous CD8+ melanoma-specific T cells

Term · Oncology and biomedicine · MLC-T-ONC-011565

Autologous CD8 T lymphocytes against melanoma-associated antigens, with potential immunomodulating and antineoplastic activities. Following leukapheresis and the ex vivo expansion of cytotoxic T-lymphocytes, the autologous CD8+ melanoma-specific T cells are re-introduced into the melanoma patient. These cytotoxic T-cells recognize and kill the patient's own melanoma cells.

Table 1. Record
IdentifierMLC-T-ONC-011565
FieldOncology and biomedicine
Synonymsautologous melanoma-specific cytotoxic T lymphocytes
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-011565",
  "term": "autologous CD8+ melanoma-specific T cells",
  "field": "Oncology and biomedicine",
  "definition": "Autologous CD8 T lymphocytes against melanoma-associated antigens, with potential immunomodulating and antineoplastic activities. Following leukapheresis and the ex vivo expansion of cytotoxic T-lymphocytes, the autologous CD8+ melanoma-specific T cells are re-introduced into the melanoma patient. These cytotoxic T-cells recognize and kill the patient's own melanoma cells.",
  "synonyms": [
    "autologous melanoma-specific cytotoxic T lymphocytes"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/autologous-cd8-plus-melanoma-specific-t-cells/"
}

Record 2,899 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.